SNORD29

Summary

SNORD29 (small nucleolar RNA, C/D box 29, HGNC:10151) is a gene on chromosome 11q12.3.

Predicted to be involved in RNA processing. Predicted to be located in nucleolus.

Source: NCBI Gene 9297 — RefSeq curated summary.

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:10151
Approved symbol	SNORD29
Name	small nucleolar RNA, C/D box 29
Location	11q12.3
Locus type	RNA, small nucleolar
Status	Approved
Aliases	U29
OMIM	603228
Entrez	9297
RNAcentral	URS0000164B86 — snoRNA, 65 nt, 3 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	0
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000055291 (11:62855272 T>G), RS1000661059 (11:62855896 C>A,G,T), RS1000988950 (11:62855843 T>A,C), RS1001419761 (11:62855320 T>C), RS1002424048 (11:62855938 A>C), RS1003477388 (11:62853524 T>A,C,G), RS1004821910 (11:62855267 T>C,G), RS1005826803 (11:62854068 A>C), RS1006912266 (11:62853601 G>A,T), RS1009121812 (11:62854522 A>G), RS1011186097 (11:62853723 C>T), RS1013070758 (11:62853914 T>C), RS1013690036 (11:62855426 C>A,T), RS1014077459 (11:62855306 T>C,G), RS1014593497 (11:62855663 T>A,C)

Disease associations

OMIM: gene MIM:603228 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
sodium arsenite	decreases expression	1
versicolorin A	increases expression	1
Aflatoxin B1	increases methylation	1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.